CLIMASTON

This brand name is authorized in Brazil, France, Tunisia.

Active ingredients

The drug CLIMASTON contains a combination of these active pharmaceutical ingredients (APIs):

1	Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol
2	Dehydroprogesterone UNII 90I02KLE8K - DYDROGESTERONE
	Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone.
	Read more about Dehydroprogesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FA14	Dydrogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500218040039803, 500218040039903
FR	Base de données publique des médicaments	66257038, 67365650, 68208043, 69652396
TN	Direction de la Pharmacie et du Médicament	5873041, 5873042, 5873043